BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23295771)

  • 1. Shared and cell type-specific mitochondrial defects and metabolic adaptations in primary cells from PINK1-deficient mice.
    Akundi RS; Zhi L; Sullivan PG; Büeler H
    Neurodegener Dis; 2013; 12(3):136-49. PubMed ID: 23295771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
    Büeler H
    Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
    Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
    J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1.
    Amo T; Saiki S; Sawayama T; Sato S; Hattori N
    Neurosci Lett; 2014 Sep; 580():37-40. PubMed ID: 25092611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
    Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
    Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.
    Glasl L; Kloos K; Giesert F; Roethig A; Di Benedetto B; Kühn R; Zhang J; Hafen U; Zerle J; Hofmann A; de Angelis MH; Winklhofer KF; Hölter SM; Vogt Weisenhorn DM; Wurst W
    Exp Neurol; 2012 May; 235(1):214-27. PubMed ID: 22265660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
    Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
    PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus.
    Agnihotri SK; Shen R; Li J; Gao X; Büeler H
    FASEB J; 2017 Jul; 31(7):2839-2853. PubMed ID: 28325755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease.
    Yao Z; Gandhi S; Burchell VS; Plun-Favreau H; Wood NW; Abramov AY
    J Cell Sci; 2011 Dec; 124(Pt 24):4194-202. PubMed ID: 22223879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells.
    Cui T; Fan C; Gu L; Gao H; Liu Q; Zhang T; Qi Z; Zhao C; Zhao H; Cai Q; Yang H
    Brain Res; 2011 Jun; 1394():1-13. PubMed ID: 21262209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Organization of Mitochondrial Quality Control and Life Cycle in the Nervous System In Vivo in the Absence of PINK1.
    Devireddy S; Liu A; Lampe T; Hollenbeck PJ
    J Neurosci; 2015 Jun; 35(25):9391-401. PubMed ID: 26109662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
    Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
    Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
    Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress.
    Huang E; Qu D; Huang T; Rizzi N; Boonying W; Krolak D; Ciana P; Woulfe J; Klein C; Slack RS; Figeys D; Park DS
    Nat Commun; 2017 Nov; 8(1):1399. PubMed ID: 29123128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
    Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
    PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.
    Gautier CA; Kitada T; Shen J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11364-9. PubMed ID: 18687901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.
    Gandhi S; Wood-Kaczmar A; Yao Z; Plun-Favreau H; Deas E; Klupsch K; Downward J; Latchman DS; Tabrizi SJ; Wood NW; Duchen MR; Abramov AY
    Mol Cell; 2009 Mar; 33(5):627-38. PubMed ID: 19285945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mitochondrial permeability transition pore by PINK1.
    Gautier CA; Giaime E; Caballero E; Núñez L; Song Z; Chan D; Villalobos C; Shen J
    Mol Neurodegener; 2012 May; 7():22. PubMed ID: 22630785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1.
    Requejo-Aguilar R; Lopez-Fabuel I; Jimenez-Blasco D; Fernandez E; Almeida A; Bolaños JP
    Biochem J; 2015 Apr; 467(2):303-10. PubMed ID: 25670069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.